Glycogen storage disease type II classification: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Classification== | ==Classification== | ||
Glycogen storage disease type II may be classified according to the age of onset and presence of [[cardiomegaly]] into 2 subtypes: | Glycogen storage disease type II may be classified according to the age of onset and presence of [[cardiomegaly]] into 2 subtypes:<ref>Leslie N, Bailey L. Pompe Disease. 2007 Aug 31 [Updated 2017 May 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1261/</ref><ref name="pmid17915568">{{cite journal| author=Di Rocco M, Buzzi D, Tarò M| title=Glycogen storage disease type II: clinical overview. | journal=Acta Myol | year= 2007 | volume= 26 | issue= 1 | pages= 42-4 | pmid=17915568 | doi= | pmc=2949314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17915568 }} </ref> | ||
{| | {| | ||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Type of GSD type 2}} | ! colspan="2" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Type of GSD type 2}} | ||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Age of onset}} | ! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Age of onset}} | ||
|- | |- | ||
| style="background: #DCDCDC; text-align: center;" |'''Infantile-onset Pompe disease (IOPD)''' | | rowspan="2" style="background: #DCDCDC; text-align: center;" |'''Infantile-onset Pompe disease (IOPD)''' | ||
| style="background: #F5F5F5;" |Age of onset before 12 months with [[cardiomyopathy]] | | style="background: #DCDCDC; text-align: center;" |'''Classic form''' | ||
| rowspan="2" style="background: #F5F5F5;" |Age of onset before 12 months with [[cardiomyopathy]] | |||
|- | |- | ||
| style="background: #DCDCDC; text-align: center;" |'''Late-onset Pompe disease (LOPD)''' | | style="background: #DCDCDC; text-align: center;" |'''Non-Classic form''' | ||
| style="background: #F5F5F5;" | | |- | ||
| rowspan="2" style="background: #DCDCDC; text-align: center;" |'''Late-onset Pompe disease (LOPD)''' | |||
| style="background: #DCDCDC; text-align: center;" |'''Childhood/Juvenile form''' | |||
| rowspan="2" style="background: #F5F5F5;" | | |||
*Age of onset before 12 months without [[cardiomyopathy]] | *Age of onset before 12 months without [[cardiomyopathy]] | ||
*Age of onset after 12 months | *Age of onset after 12 months | ||
|- | |||
| style="background: #DCDCDC; text-align: center;" |'''Adult form''' | |||
|} | |} | ||
Revision as of 15:42, 12 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II classification On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II classification |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Glycogen storage disease type II may be classified according to the age of onset and presence of cardiomegaly into 2 subtypes including infantile-onset Pompe disease (IOPD) and late-onset Pompe disease (LOPD).
Classification
Glycogen storage disease type II may be classified according to the age of onset and presence of cardiomegaly into 2 subtypes:[1][2]
Type of GSD type 2 | Age of onset | |
---|---|---|
Infantile-onset Pompe disease (IOPD) | Classic form | Age of onset before 12 months with cardiomyopathy |
Non-Classic form | ||
Late-onset Pompe disease (LOPD) | Childhood/Juvenile form |
|
Adult form |
References
- ↑ Leslie N, Bailey L. Pompe Disease. 2007 Aug 31 [Updated 2017 May 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1261/
- ↑ Di Rocco M, Buzzi D, Tarò M (2007). "Glycogen storage disease type II: clinical overview". Acta Myol. 26 (1): 42–4. PMC 2949314. PMID 17915568.